Clopidogrel Testing Comes Under Fire

27 December 2011

A new study by Dr Michael Holmes (UCL Epidemiology & Public Health) and colleagues has casts doubt on the usefulness of a highly touted genetic test for patients taking the popular anti-clotting drug Clopidogrel. Read: Forbes More: Wall Street Journal (£)